GSK Eliminates 650 U.S. Jobs in Restructuring

GlaxoSmithKline (GSK) has disclosed it is eliminating 650 U.S. jobs as part of the restructuring it announced in July.The job cuts consist of 450 “field” sales positions, and 200 back office / support positions—“about 100” each in Philadelphia and North Carolina’s Research Triangle Park, GSK said in a statement.“In the US, we are facing several external and internal drivers of change as we look at our Pharma business over the next several years. Although